Clinical Trial Update: Control of Assistive Devices Via Brain-Computer Interface Technology [NA]

View source ↗

Summary

A clinical trial update indicates that Neuralink's brain-computer interface study NCT06710626 is currently enrolling by invitation, investigating use in tetrapl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis
• Spinal Cord Injury

Snippet

Sponsor: Neuralink Corp | Conditions: Tetraplegia/Tetraparesis, Amyotrophic Lateral Sclerosis (ALS) | NA | Status: ENROLLING_BY_INVITATION